Hematology Billing Services Built Around the Full Diagnostic RCM
Hematology billing can lose revenue through small errors that are easy to miss but expensive to ignore. Our hematology billing services connect each revenue event to the right coding, documentation, and claim pathway to reduce missed charges, prevent unsupported billing, and improve reimbursement control.
Request Your Consultation
59 %
Cost to Collect Reduced by
30 %
Client Revenue Increased by
500 +
Happy Clients
98 x
Collection Rate
Where Hematology Revenue Gets Lost Without Professional Expertise
Specimen-to-Charge Gaps Across Laboratory & Clinical Work
Some hematology revenue is lost before billing starts. A test may be completed, documented, and clinically useful, yet never make it onto the final claim correctly. Professional teams check orders, lab activity, procedure records, and charges against each other so completed work is captured and billed with the right support.
Coding Units and Test Relationships That Do Not Match the Work
Even a complete hematology claim can lose value when codes, units, or related services are reported incorrectly. Experts check how services should be billed together, apply the right unit logic, and catch NCCI or MUE conflicts before submission. This helps reduce avoidable denials, underpayments, and compliance risk without overcomplicating the claim.
Medical Necessity and Payment Ownership Breakdowns
A test can be clinically appropriate and still struggle at the payer level. If the diagnosis, coverage rules, authorization, or lab details do not line up, the claim can stall quickly. Professionals check these requirements before submission, so high-value hematology testing has the support it needs to move toward payment.
Our Hematology Billing and RCM Services
Hematology billing does not move through one simple encounter-to-claim workflow. Our hematology medical billing services connect these revenue events to the documentation and payer logic behind them, so clinically completed work does not become financially invisible. Our comprehensive hematology medical billing services include;
Hematology Coding and Documentation Control
Hematology coding depends on more than selecting a procedure from an encounter note. We review orders, diagnosis specificity, specimen information, procedure documentation, laboratory results, repeat-testing rationale, and associated physician services before the claim is released. That creates stronger linkage between clinical intent and billed service while reducing errors caused by missing documentation, incorrect units, incomplete diagnosis support, or disconnected laboratory and professional workflows.
Hematology Laboratory Billing Services
Our hematology laboratory billing workflow covers CBC and differential testing, reticulocyte studies, coagulation testing, iron studies, peripheral blood evaluations, and other diagnostic laboratory services. Each claim is checked for ordering information, performing laboratory, service date, units, code relationships, payer policy, and CLIA-related billing requirements. The goal is not simply faster submission. It is a claim that accurately represents the test performed and its billing context.
Bone Marrow and Hematopathology Billing
Bone marrow encounters can create multiple revenue events across aspiration or biopsy, specimen preparation, pathology evaluation, ancillary studies, and physician work. We reconcile the procedure note with the specimens and downstream diagnostic services before billing. This prevents the marrow procedure and the diagnostic work performed on the specimen from being treated as unrelated charges, while also reducing unsupported duplication and missed hematopathology revenue.
Flow Cytometry and Molecular Testing Claims
Flow cytometry and molecular testing require precise service-level control. For flow cytometry, marker acquisition and interpretation follow different reporting logic, while molecular claims may depend on the gene tested, methodology, diagnosis, and coverage policy. CMS guidance identifies 88184/88185 for technical flow-cytometry marker work and 88187–88189 for interpretation, with one interpretation code applying to the specimen. Our workflow validates those relationships before claim submission.
Medical Necessity and Hematology Denial Prevention
We examine the reason for the test before the payer examines the claim. Diagnosis linkage, coverage criteria, repeat-testing rationale, authorization requirements, and applicable payer policies are reviewed upstream rather than after denial. This is particularly important for molecular hematology and specialized diagnostic testing, where the same laboratory service may be covered for one clinical indication and challenged for another. Prevention reduces rework without weakening coding compliance.
Hematology A/R and Underpayment Recovery
A paid claim can still represent lost revenue. Our hematology A/R team tracks unresolved claims, partial payments, payer reductions, laboratory denials, contractual variances, and aged balances against the expected reimbursement path. Payment posting therefore becomes a control point rather than an endpoint. Exceptions are routed back to coding, eligibility, authorization, contracting, or denial teams so recurring payment defects can be corrected at their source.
What Expertise You Get With UControl Billing
Hematology claims cross clinical, laboratory, pathology, and payer systems that do not always speak the same billing language. Our team works at those handoff points. We connect specimen activity with charges, diagnoses with medical necessity, procedures with pathology output, code units with payer edits, and remittances with expected payment. That gives your hematology revenue cycle management process stronger control from test order through final reimbursement.
Hematology Coding Services with Correct Diagnostic Logic
Hematology coding is highly dependent on what was ordered, performed, interpreted, and clinically supported. A single diagnostic workup may involve automated blood counts, morphology, bone marrow sampling, immunophenotyping, pathology work, and molecular analysis. We examine these services as one diagnostic chain rather than processing each charge without context.
Our hematology coding services focus on the code families and service relationships most likely to produce unit errors, bundling issues, medical-necessity denials, missed charges, or payer review. This creates a stronger bridge between laboratory operations, physician documentation, and the final claim.
85000 Series | CBC and Hematology Testing
We distinguish complete blood counts, differential testing, reticulocyte studies, and related hematology work while checking component relationships, units, and medical necessity. CMS identifies 85025 as an automated CBC with automated differential.
85600–85700 Range | Coagulation Testing
We align coagulation claims such as PT/INR and PTT testing with the ordered service, diagnosis, repeat-testing need, date of service, and payer rules. We also catch documentation or coding gaps early so avoidable denials do not hold up reimbursement.
38220–38222 | Bone Marrow Procedures
Aspiration, biopsy, and combined marrow procedures are checked against procedure documentation so the billed service corresponds to what was actually performed. CMS data identifies 38222 as combined diagnostic bone marrow biopsy and aspiration.
88184–88189 | Flow Cytometry
We separate technical marker work from professional interpretation and check marker counts, specimen-level reporting, payer policy, and duplicate-testing exposure before submission.
88300 Series | Hematopathology Services
Bone marrow and tissue-related pathology claims are connected to specimen processing, interpretation, special preparation, and applicable component billing instead of being treated as isolated charges.
Molecular Pathology | JAK2, CALR and MPL
We validate molecular claims against documented clinical indication, diagnosis linkage, test identity, coverage criteria, and payer policy before release. CMS coverage articles include JAK2, CALR, and MPL testing within specific molecular-pathology criteria.
Repeat Laboratory Testing | Modifier 91
We distinguish clinically necessary repeat testing from duplicate or rerun testing before modifier 91 is applied. CMS states that modifier 91 is for medically necessary repeat clinical diagnostic laboratory testing, not reruns caused by specimen or equipment issues.
NCCI and MUE Validation
We screen hematology claims for PTP edit relationships and unit-of-service limits before submission, reducing avoidable denials and unsupported code quantity. We also review modifier use and service combinations so claims reflect the work performed without triggering unnecessary payer edits.
Hematology Claims Form Expertise
Hematology claims can cross professional, laboratory, pathology, hospital, and outpatient payment systems during the same diagnostic episode. Our hematology billing company determines which entity performed the service, which claim pathway applies, and which identifiers and supporting data belong on that claim. We manage CMS-1500 professional billing, UB-04 institutional workflows, 837P and 837I electronic transactions, laboratory claim data, diagnosis sequencing, service locations, and supporting documentation so the final submission reflects the actual billing relationship.
CMS-1500 Accuracy for Professional and Laboratory Claims
We validate provider data, diagnosis pointers, service lines, units, modifiers, CLIA-related information when applicable, and place-of-service details before professional or laboratory claims are transmitted.
UB-04 Control for Hospital-Based Hematology
Facility hematology services are aligned with institutional claim requirements, revenue-cycle data, service dates, departmental charges, payer edits, and hospital billing rules before adjudication.
837P, 837I and Electronic Claim Validation
Electronic claims are checked for data consistency between practice systems, laboratory records, clearinghouse edits, payer requirements, and supporting clinical information before they enter the payer queue.
Hematology Denial Management Services Expertise
Hematology denials should not be managed as isolated CARC or RARC messages. The adjustment code identifies what the payer did, but not always why the revenue cycle produced that result. We trace the claim backward through ordering, diagnosis linkage, accession data, coding, units, medical necessity, authorization, CLIA information, submission, and adjudication. Our hematology denial management services correct the specific failure while feeding the root cause back into the workflow that created it.
Root-Cause Hematology Denial Analysis
We separate coverage, diagnosis, coding, unit, duplicate, authorization, laboratory credentialing, and documentation failures so corrective work targets the real revenue defect.
Appeals Supported by Diagnostic Evidence
Appeals connect payer policy with the order, clinical indication, laboratory or pathology report, coding rationale, prior claim activity, and supporting medical record.
Recovery Data Fed Back Into Billing
Every recovered or upheld denial becomes process data, allowing recurring defects by test, payer, provider, diagnosis, or workflow stage to be identified earlier.
Hematology Billing Case Study
Turning Fragmented Diagnostic Charges Into a Controlled Hematology Claim Path
The practice had no reliable reconciliation between ordered tests, marrow procedures, resulting pathology work, and final billed charges. Flow cytometry and molecular claims also entered billing through separate workflows. The result was missed charges, duplicate edits, medical-necessity denials, and aging balances that could not be traced back to one consistent operational cause.
Diagnostic work was being completed clinically but losing financial continuity between specimen processing and payer adjudication.
We linked procedure documentation, laboratory orders, accession activity, resulting diagnostic services, and submitted claims so completed work could be traced through the revenue cycle.
We created separate validation paths for routine hematology testing, marrow procedures, flow cytometry, hematopathology, and molecular diagnostics instead of processing every laboratory charge identically.
Denials were categorized by coverage, diagnosis, unit, duplicate, authorization, payer, and documentation cause so corrective action could be moved upstream.
Hematology Billing Services for Different Practice Models
The revenue path changes with the care model. We support hematologists, physician groups, diagnostic laboratories, hematopathology teams, and hospital-linked practices with billing workflows matched to their actual testing, procedure, documentation, and payer relationships.
Independent Hematology Practices
We manage evaluation, laboratory, procedure, denial, and A/R workflows for private hematology practices with in-house or external diagnostic relationships.
Hematology-Oncology Groups
Our workflows coordinate hematology diagnostics with higher-complexity treatment and administration billing when hematology and oncology services operate inside the same practice.
Hematopathology Practices
We support specimen-driven pathology billing where processing, interpretation, ancillary studies, and professional-versus-technical responsibility affect final reimbursement.
Diagnostic Hematology Laboratories
Laboratory claims are controlled around orders, CLIA status, performing location, test coding, medical necessity, units, and payer-specific claim requirements.
Hospital-Based Hematologists
We separate physician services from hospital resources and align professional claims with place of service, documentation, and institutional billing activity.
Multi-Location Hematology Groups
Centralized billing controls standardize charge capture, coding, payer edits, denial routing, and A/R reporting across providers, laboratories, and locations.
See What Your Hematology Revenue Cycle Is Failing to Capture
Get expert feedback on the financial path from diagnostic service to payment.
Medical Billing Certifications and Hematology Compliance Standards
Hematology billing operates inside both revenue-cycle and laboratory-compliance frameworks. Our processes account for HIPAA requirements, payer billing rules, CLIA-related laboratory controls, current coding guidance, NCCI edits, MUEs, and applicable Medicare coverage policy. CMS requires laboratories testing human specimens for diagnosis, prevention, or treatment to hold the appropriate CLIA certification, subject to applicable exceptions.
Explore Frequently Asked Questions
We identify the complete test performed before billing individual components. A bundled CBC should not be reconstructed from separately reported components simply because those values appear in the result. We also check current NCCI relationships, units, diagnosis support, and payer rules before submission. CMS has specifically addressed CBC bundling in its coding guidance.
Our Hematology billing services experts first establish why the test was repeated. Modifier 91 may apply when the same clinical laboratory test is medically necessary again during treatment to obtain another result. It should not be used merely because a specimen or equipment problem required a rerun or because the first result needs confirmation.
We compare the procedure note with the actual marrow service, specimen record, and downstream diagnostic work before the claim is created. This determines what procedure occurred and prevents the marrow collection procedure from becoming disconnected from hematopathology, flow cytometry, or molecular services generated from the specimen.
Marker quantity, technical work, specimen identity, and interpretation are validated separately. CMS guidance uses 88184 for the first technical marker, 88185 for additional markers, and 88187–88189 for interpretation based on the applicable service. CMS also states that only one flow-cytometry interpretation code should be reported for all flow cytometry performed on a specimen.
We verify the ordered test, molecular target, clinical indication, diagnosis, performing laboratory, payer policy, and coverage criteria before billing. This matters because molecular coverage can be indication-specific. CMS coverage guidance, for example, addresses JAK2, CALR, and MPL testing in connection with defined diagnoses and coverage requirements.
We do not close the account simply because a remittance contains payment. The allowed amount, units, code processing, contractual adjustment, laboratory payment methodology, modifiers, and payer response are compared with expected reimbursement. A payment variance is then routed for correction, appeal, contractual review, or recovery instead of disappearing into routine posting.